SARS-CoV-2 Infection of Airway Epithelial Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, Gwanghui | - |
dc.contributor.author | Shin, Hyun-Woo | - |
dc.date.accessioned | 2021-08-11T08:30:04Z | - |
dc.date.available | 2021-08-11T08:30:04Z | - |
dc.date.issued | 2021-02 | - |
dc.identifier.issn | 1598-2629 | - |
dc.identifier.issn | 2092-6685 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2048 | - |
dc.description.abstract | Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide since its outbreak in December 2019, and World Health Organization declared it as a pandemic on March 11, 2020. SARS-CoV-2 is highly contagious and is transmitted through airway epithelial cells as the first gateway. SARS-CoV-2 is detected by nasopharyngeal or oropharyngeal swab samples, and the viral load is significantly high in the upper respiratory tract. The host cellular receptors in airway epithelial cells, including angiotensin-converting enzyme 2 and transmembrane serine protease 2, have been identified by single-cell RNA sequencing or immunostaining. The expression levels of these molecules vary by type, function, and location ofairway epithelial cells, such as ciliated cells, secretory cells, olfactory epithelial cells, and alveolar epithelial cells, as well as differ from host to host depending on age, sex, or comorbid diseases. Infected airway epithelial cells by SARS-CoV-2 in ex vivo experiments produce chemokines and cytokines to recruit inflammatory cells to target organs. Same as other viral infections, IFN signaling is a critical pathway for host defense. Various studies are underway to confirm the pathophysiological mechanisms of SARS-CoV-2 infection. Herein, we review cellular entry, host-viral interactions, immune responses to SARS-CoV-2 in airway epithelial cells. We also discuss therapeutic options related to epithelial immune reactions to SARS-CoV-2. | - |
dc.format.extent | 16 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한면역학회 | - |
dc.title | SARS-CoV-2 Infection of Airway Epithelial Cells | - |
dc.title.alternative | SARS-CoV-2 Infection of Airway Epithelial Cells | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4110/in.2021.21.e3 | - |
dc.identifier.scopusid | 2-s2.0-85102762147 | - |
dc.identifier.wosid | 000626257600003 | - |
dc.identifier.bibliographicCitation | Immune Network, v.21, no.1, pp 1 - 16 | - |
dc.citation.title | Immune Network | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 16 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002692700 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | ANGIOTENSIN-CONVERTING ENZYME-2 | - |
dc.subject.keywordPlus | FUNCTIONAL RECEPTOR | - |
dc.subject.keywordPlus | SARS CORONAVIRUS | - |
dc.subject.keywordPlus | ACE2 | - |
dc.subject.keywordPlus | COVID-19 | - |
dc.subject.keywordPlus | LUNG | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | TMPRSS2 | - |
dc.subject.keywordPlus | INNATE | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Coronavirus | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | Respiratory system | - |
dc.subject.keywordAuthor | Epithelial cells | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.